 | |
| Clinical data | |
|---|---|
| Other names | 2-Ethoxy-MMDA-2; 2-EtO-MMDA-2; 2-Ethoxy-4,5-methylenedioxyamphetamine |
| Routes of administration | Oral[1][2] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| PubChemCID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H17NO3 |
| Molar mass | 223.272 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
EMDA-2, also known as2-ethoxy-4,5-methylenedioxyamphetamine, is apsychedelic drug of thephenethylamine andmethylenedioxyamphetamine families.[1][2][3] It is theanalogue ofMMDA-2 in which the 2-methoxy group has been replaced with a 2-ethoxy group.[1][2] This has resulted in EMDA-2 being described as the "TWEETIO" analogue of MMDA-2.[1]
EMDA-2's dose is approximately 135 to 185 mg and itsduration is about 10 to 12 hours.[1][2] At 135 mg, it producedclosed eye visuals, including intense colors, withsleep disturbances and a duration of some 10 hours.[1] At 185 mg, its effects were stronger, including "marvelous" closed-eye visuals with "incredible" colors, goodconcentration, and distinctbody tingles andrushes, withinsomnia and a duration of about 12 hours.[1] Thepotency of EMDA-2 is about one-third that of MMDA-2.[1]
EMDA-2 appears to have first been described in thescientific literature by at least 1975.[3] Its effects in humans were described byAlexander Shulgin in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[1][2]